IntelliEPI Cayman (4971) - Total Liabilities

Latest as of September 2025: NT$105.65 Million TWD ≈ $3.33 Million USD

Based on the latest financial reports, IntelliEPI Cayman (4971) has total liabilities worth NT$105.65 Million TWD (≈ $3.33 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore IntelliEPI Cayman (4971) cash conversion ratio to assess how effectively this company generates cash.

IntelliEPI Cayman - Total Liabilities Trend (2011–2024)

This chart illustrates how IntelliEPI Cayman's total liabilities have evolved over time, based on quarterly financial data. Check 4971 asset resilience ratio to evaluate the company's liquid asset resilience ratio.

IntelliEPI Cayman Competitors by Total Liabilities

The table below lists competitors of IntelliEPI Cayman ranked by their total liabilities.

Company Country Total Liabilities
Chutian Dragon Co Ltd
SHE:003040
China CN¥499.03 Million
Aedas Homes SL
MC:AEDAS
Spain €1.23 Billion
Cello World Limited
NSE:CELLO
India Rs2.64 Billion
Guangzhou Dongfang Hotel Co Ltd
SHE:000524
China CN¥1.55 Billion
Monex S.A.B. de C.V
MX:MONEXB
Mexico MX$190.09 Billion
Wereldhave NV
AS:WHA
Netherlands €1.30 Billion
Vivenio Residencial SOCIMI S.A.
MC:YVIV
Spain €516.27 Million

Liability Composition Analysis (2011–2024)

This chart breaks down IntelliEPI Cayman's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 4971 stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 6.74 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.06 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.05 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how IntelliEPI Cayman's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for IntelliEPI Cayman (2011–2024)

The table below shows the annual total liabilities of IntelliEPI Cayman from 2011 to 2024.

Year Total Liabilities Change
2024-12-31 NT$262.17 Million
≈ $8.26 Million
-9.85%
2023-12-31 NT$290.82 Million
≈ $9.16 Million
+129.97%
2022-12-31 NT$126.46 Million
≈ $3.98 Million
+13.03%
2021-12-31 NT$111.88 Million
≈ $3.52 Million
+40.96%
2020-12-31 NT$79.37 Million
≈ $2.50 Million
+10.22%
2019-12-31 NT$72.01 Million
≈ $2.27 Million
-6.88%
2018-12-31 NT$77.33 Million
≈ $2.44 Million
-12.82%
2017-12-31 NT$88.71 Million
≈ $2.79 Million
-4.40%
2016-12-31 NT$92.78 Million
≈ $2.92 Million
+15.02%
2015-12-31 NT$80.67 Million
≈ $2.54 Million
-76.00%
2014-12-31 NT$336.11 Million
≈ $10.59 Million
+506.25%
2013-12-31 NT$55.44 Million
≈ $1.75 Million
+17.66%
2012-12-31 NT$47.12 Million
≈ $1.48 Million
+7.55%
2011-12-31 NT$43.81 Million
≈ $1.38 Million
--

About IntelliEPI Cayman

TWO:4971 Taiwan Semiconductors
Market Cap
$996.48 Million
NT$31.63 Billion TWD
Market Cap Rank
#9129 Global
#282 in Taiwan
Share Price
NT$791.00
Change (1 day)
+4.49%
52-Week Range
NT$89.80 - NT$872.00
All Time High
NT$872.00
About

IntelliEPI Inc. (Cayman), together with its subsidiaries, produces and sells epitaxy wafers of compound semiconductor for use in wireless communications, data transmission and national defense in the United States, Germany, Korea, Japan, China, and internationally. The company utilizes its proprietary real-time in situ growth monitoring technology on molecular beam epitaxy (MBE) systems for the m… Read more